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Abstract  
Introduction: hypertension is a global public health burden. Angiotensin receptor blockers (ARBs) have proven efficacy in the management of  
hypertension and related complications. The Internet has become a major source of health information for patients and healthcare professionals. 
The study aimed to assess the quality and readability of internet-based information related to selected Angiotensin Receptor Blockers (ARBs). 
Methods: the three most widely used ARBs were identified from published literature, after which internet-based patient information was identified 
from the first five pages of three search engines (Google, Yahoo and Bing). Quality of identified websites were assessed using the DISCERN 
instrument, while readability was evaluated using the SMOG instrument and the Flesch-Kincaid readability algorithm. Final ratings were then 
calculated as described by the instruments developers. Further, inter-class correlation coefficients (ICC) were calculated using the Statistical Package 
for Social Sciences. Results: the average overall DISCERN score in this study was 2.99 (SD±1.05). No website received an excellent rating, 15% 
were rated good, 66% as moderate and 19% as poor. The inter-class reliability was 0.804 for losartan and 0.695 for valsartan. The mean Flesch 
Reading Ease score for the websites was 48.87 (SD±16.12), mean Flesch-Kincaid Reading Grade Level was 9.29 (SD±1.98) while mean SMOG value 
was 11.29 (SD±1.70). Conclusion: overall, patient information on the reviewed ARBs websites was found to be of moderate quality and suboptimal 
readability. Content providers on websites should ensure that health information is of favorable quality and easy to read by patients with varying 
degree of health literacy.  
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Introduction 
 
The internet has rapidly become the largest source of information 
worldwide [1] and an important source of health information both for 
patients and health professionals [2]. With the advent of the internet, 
medical information is easily accessed with the click of a mouse for 
several disease conditions requiring short-term or long-term 
therapy [3]. Studies have showed that in Canada and the United 
States, more than 80% of the population have access to the 
internet [4], and about 72% of United State users seek information 
over the internet [5]. Studies have also showed that health 
information are among the most sought after topics on the 
internet [6], not necessarily as a means of replacing advice given by 
health professionals, but for validation of information given and to 
gather additional information [7]. Increasingly, patients and health 
professionals are turning to the internet for information pertaining to 
health challenges and complicated therapies [8]. One of such health 
challenges is hypertension, which is a major risk factor for 
cardiovascular diseases (CVD) [9]. In a study conducted in 2013 at 
the Pew Research Center, 45% of adults in the United States reported 
that they live with one or more chronic conditions including 
hypertension, lung conditions, diabetes and heart disease [10]. Sixty-
seven percent of those living with hypertension were internet users, 
and 58% of them accessed websites that provided information about 
a specific medical condition or problem [10]. Hypertension is a global 
public health burden that contributes to morbidity, mortality and 
healthcare cost in both developing and developed countries [11]. 
Approximately 25% of hypertensive patients worldwide are taking 
ARBs, and about 20 million people worldwide take ARBs for both 
hypertension and other cardiovascular conditions [12]. The 
effectiveness and safety of ARBs are well established [13]. However, 
its use has been associated with a number of adverse drug events, 
especially in elderly patients. Providing quality patient information and 
education is therefore important for safe and effective hypertension 
management. Despite its potential as a significant patient information 
resource, the internet's usefulness is often limited by the challenges 
associated with finding good quality information that comes from 
reliable and authentic sources [14]. Previous studies have reported 
that more than half of websites provide poor quality health 
information [15]. Health professionals are therefore constantly faced 
with patients who have been informed or misinformed by the 
internet [16]. As a result, clinicians, researchers, and consumers are 
concerned about the quality and accuracy of online health information 
and it is essential to assess the validity [17]. As much as disseminating 
health information on the internet can help improve knowledge 
transfer from health professionals to the population and help 
individuals maintain and improve their health, the rapid development 
of medical information on the Internet has its shortcomings which 
include: 1) uneven quality of medical information available on the 
Internet [18]; 2) difficulty in reading and understanding this 
information due to use of technical language [19]; and 3) potential 
dangers related to its erroneous and unsuitable use [20]. In addition 
to addressing the issue of quality, accuracy and reliability, it is also 
imperative to systematically assess the presentation of online health 
information using readability algorithms to ensure that such 
information is easily read and understood. We therefore aimed to 
assess the quality and readability of Internet-based health information 
related to select Angiotensin Receptor Blockers (ARBs).  
  
  
Methods 
 
Search strategy  
  
Identification and selection of websites  
  
We identified the three most widely used Angiotensin Receptor 
Blockers from published literature: losartan, irbesartan and 
valsartan [21]. Each of these key terms ‘losartan', ‘irbesartan', 
‘valsartan' and ‘patient education' were entered into three different 
search engines (Google, Yahoo, Bing) chosen based on their 
widespread use [22], in March 2017. Only the first 50 links reported 
by each search engine were identified, as studies have showed that 
web users only visit the top 10 websites listed in search results [23].  
  
Websites were included in the research if they were in English 
Language and free to access, and if they provided patient information 
relating to any of the search terms. Websites designed for marketing 
purposes evident by the presence of diverse advertisements were 
excluded [24]. News feeds, video feeds, abstract listings and duplicate 
websites were also excluded. Additionally, websites for co-formulated 
ARB products were excluded. The quality of identified sites was 
evaluated using the DISCERN questionnaire, while readability was 
assessed using the SMOG calculator and Flesch-Kincaid algorithm.  
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Assessment of quality of information using DISCERN 
instrument  
  
The DISCERN questionnaire is a valid instrument that was designed 
to enable patients (or health consumers) and health care providers to 
assess the quality of health information. This questionnaire was 
developed based on the input of an expert panel, health information 
providers and representative of patient population [25]. The DISCERN 
tool is freely accessible online and a downloadable version of the 
DISCERN instruction handbook is available from the DISCERN 
handbook [26]. It is suitable for anyone who utilizes or produces 
information about treatment choices. Its uses include an aid for 
individual consumers who are making decisions about treatment, a 
screening tool for health information providers, a checklist for authors 
and producers of written consumer health information, a training tool 
for health professionals to improve communication and shared 
decision-making skills. The DISCERN questionnaire, consisting of 16 
questions, was used to evaluate the quality of information on the 
selected websites. These questions are organized into three sections 
[26]. Section 1 (questions 1 to 8) addressed the reliability of the 
publication and helps in considering whether it can be trusted as a 
source of information. Section 2 (questions 9 to 15) focused on the 
specific details of the information about treatment choices while 
Section 3 (question 16) assessed the overall quality rating. Each 
question was rated on a 5-point scale ranging from "no" to "yes". A 
score of "5" indicates a definite yes; a score of "2-4" indicates that the 
publication meets the criterion in the question to an extent; while a 
score of "1" indicates a definite no.  
  
Readability assessment  
  
It is generally accepted that in evaluating the readability scores of 
written information, the use of more than one readability formula 
improves the reliability of the readability scores [27], hence two 
readability formulae; SMOG formula [28], and Flesch-Kincaid 
algorithm [29] were used in this study. The SMOG readability formula 
was created by G Harry McLaughlin in 1969 and it estimates the years 
of education a person needs to understand a piece of writing [28]. 
SMOG readability grades were measured using the manual SMOG 
formula [28]. The SMOG was then calculated as described by 
McLaughlin et al. [28]. The readability scores were calculated using 
Microsoft Office Word. The Flesch Reading Ease test rates the text on 
the given website on a 100-point scale. The higher the score, the 
easier it is to understand the document. The Flesch-Kincaid Grade 
Level test rates a text on a United States school grade level. A score 
of 8.0, for example, means that an eighth grader can understand the 
document.  
  
Statistical analysis: standard data entry and analysis were done 
using a Microsoft Excel spreadsheet (edition 2013). Inter-class 
Correlation Coefficient (ICC) value was calculated using the Statistical 
Package for Social Sciences, version 23 (IBM, Armonk, New York, US). 
 
 
Results 
 
A total of 450 websites were reviewed between April 2017 and 
September 2017- a total of 150 websites for each of the three search 
engines (Google, Yahoo and Bing). Removal of 363 duplicate websites 
left a total of 87 unique sites. Thirty-seven out of the 87 unique 
websites met the inclusion criteria and were eligible to be evaluated. 
The remaining 50 websites were excluded as 11 were not freely 
accessible, 2 had broken link and 37 did not provide information useful 
for patient education. The authors further streamlined the search 
results leaving only websites with patient information on losartan and 
valsartan considering they are the most frequently prescribed ARBs as 
reported in the literature [30]. This left a total of 24 websites for 
evaluation. The Inter-class reliability for losartan and valsartan was 
calculated to be 0.804 and 0.695, respectively (Table 1).  
  
Assessment of quality of websites  
  
From the evaluation conducted using the DISCERN tool, none of the 
websites scored 5 for question 16 (the overall quality rating at the end 
of the questionnaire), 15% were rated as good, 66% as moderate, 
while 19% were rated as poor. The overall mean DISCERN score was 
2.99 (SD±1.05). The mean quality rating across the websites is shown 
in Figure 1. From a maximum score of 5, the mean score for the 
questions 1 to 8 that addressed reliability was 2.82 while for questions 
9 to 15 that focused on information regarding treatment choice was 
3.20. The questions with the highest response score were as follows: 
"Does it describe risk of each treatment?", "Does it describe the 
benefit of each treatment?", "Does it provide support for shared 
decision-making?" and "is it relevant?" On the other hand, the lower 
scoring questions are: "Is it clear what sources of information are used 
to compile the publication?", "Does it describe what would happen if 
no treatment is used?" and "Does it describe how the treatment choice 
affects the overall quality of life?" The highest-rated websites 
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according to our analysis are Mayo Clinic (Valsartan) 3.84 and Patient 
Info (Losartan) 3.84 [31, 32].  
  
Readability assessment  
  
Twenty-four websites were assessed for readability Table 1. The mean 
Flesch Reading Ease Score (FRES) was 48.87 (SD±16.12), while the 
mean Flesch-Kincaid Reading Grade Level (FKRGL) was 9.29 
(SD±1.98). The mean SMOG value was calculated to be 11.29 
(SD±1.70). 
  
  
Discussion 
 
The Internet has the potential to provide patients and health 
professionals with health information, but with the increase in use, 
concerns arise as to the quality, reliability and readability of the 
information obtained from the internet [33]. In addressing these 
concerns, several solutions have been proposed. These solutions have 
included electronic filtering of web-based information, creation of 
ethical codes of conduct for providers of web-based information 
(currently done on voluntary basis) and assessment of websites by 
health professionals [33]. Introduction of clear critical appraisal tools 
with standardized website evaluation systems also appears to be 
useful in improving the ability of users to differentiate between 
trustworthy sites and inadequate ones [33].  
  
This study is the first to have systematically evaluated the quality and 
readability of internet-based information related the two mostly 
prescribed ARBs. The results from this investigation provide some 
insights regarding online health information related to the ARBs. The 
overall mean DISCERN score for the 26 websites was 2.99 (SD±1.05). 
This suggests that information on ARBs on most of the evaluated 
websites was of moderate quality. This analysis is consistent with 
findings from previous studies which have evaluated the quality of 
health information on the Internet for a range of different chronic 
diseases (Table 2) [15, 34-36].  
  
With respect to the quality of health information, most of the websites 
assessed scored reasonably well in describing the benefits of 
treatment as well as the risks of using ARBs. Most websites evaluated 
were also balanced and unbiased, and providing support for shared 
decision making between patients and physician. This is in agreement 
with the DISCERN criterion which suggests that a good quality health 
information resource should include issues for patients to discuss with 
their healthcare practitioners. However, most of the websites fared 
poorly in identifying clear sources of information or references, as only 
five websites met this criterion. This is important because clear 
sources enable online users examine the credibility and reliability of 
information on the website or decide to seek further information.  
  
There was consistently a lack of information on the likely consequence 
of no treatment and how treatment choices affect the overall quality 
of life. Hence, patients receiving ARB therapy would potentially have 
poor knowledge on this aspect of their therapy. From the present 
study, certain websites are Mayo Clinic (Valsartan) 3.84 and Patient 
Info (Losartan) 3.84, received the highest DISCERN score [31, 32]. 
These websites were seen to have clearly met a good number of the 
DISCERN criteria.  
  
The inter-class reliability determined in the study was 0.804 for 
losartan and 0.695 for valsartan. Ideally a value of 0.7 is considered 
optimal [37]. Therefore, the values gotten indicated a good level of 
consistency for quality rating measurements between independent 
raters. This study highlights that most of the websites had patient 
information that is potentially difficult to read, as most of the websites 
were written at readability grade levels higher than grade 8 (Table 3). 
Of note, the SMOG rating scale was observed to provide a 
measurement of 2-4 grade levels higher than the Flesch-Kincaid grade 
(Table 1). This is considered the result of variation between different 
measurement scales and is consistent with studies conducted by 
Wilson, 2009 [38]. However, for both scales, most websites 
consistently scored above "9" indicating the universality of the 
readability problem.  
  
The suboptimal readability observed in the present study is consistent 
with those of the broader literature. Estrada et al., reported that 
patient education materials related to the use of anticoagulants were 
written at grade levels beyond the comprehension of most 
patients [39]. Hutchinson et al., have also evaluated websites 
containing medical information pertaining to nine common general 
medicine diagnoses, and have reported similar readability levels 
beyond grade 8 for many of the websites evaluated [40]. Our finding 
is particularly relevant because hypertension is common in the elderly, 
and its prevalence increases with aging which has been associated 
with decline in cognitive function [41]. As such, patients on ARBs 
might find it difficult to read and understand ambiguous online 
materials. Hence, patient information on these sites should be written 
at approximately school grade 8 or less to enhance easy 
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understanding. The Institute of Healthcare Improvement recommends 
using simpler words, shorter sentences and avoiding medical jargon, 
all of which are important considerations in the provision of online 
health information for public consumption [42].  
  
Limitations  
  
The present study is not without a number of limitations. Only the first 
50 search results per search engine were reviewed, and only the two 
mostly prescribed ARBs were assessed. Further, only websites written 
in English were evaluated. Hence, findings may not be applicable to 
other languages. The Flesch-Kincaid readability tool used may have 
overestimated the required readability scores as a list of polysyllabic 
clinical and medical terms such as ‘angiotensin' and ‘aldosterone' may 
be regarded as one sentence. Finally, readability formulae used was 
limited by the lay out of the website page. Websites vary dramatically 
in how they present information separately from the text that is 
written. Despite these limitations, the present study provides evidence 
on suboptimal readability and the need for quality improvement for 
online ARB patient education material. 
  
  
Conclusion 
 
While the overall quality of health information on the selected ARBs is 
moderate, the websites were found to possess a suboptimal 
readability score. Future content developers of ARB patient education 
material should ensure that health information is of favorable quality 
and easy to read by patients with varying degree of health literacy.  
 
What is known about this topic 
 The internet is an important source of health information;  
 Health information on the internet varies widely in quality 
and a significant number of online health information are 
written at inappropriate reading levels, which could limit 
their usefulness.  
What this study adds 
 Health information on the reviewed ARBs websites was 
found to be of moderate quality with written language 
above recommended reading level;  
 Improving the quality of health information available to 
patients will potentially lead to better treatment outcome.  
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Table 1: readability scores of ARB websites (N=24) 
Name of website Flesch ease 
reading 
Flesch kincaid 
grade level 
Smog 
value 
 http://www.upmc.com/patients-visitors/education/cardiologydrugs/Pages/losartan.aspx  57.6 7.7 10.62 
 http://www.mayoclinic.org/drugs-supplements/losartan-oralroute/description/drg-20067341  35.6 12.57 12.16 
https://patient.info/medicine/losartan-an-angiotensin-receptor-blockercozaar  59.4 8.7 10.43 
http://www.rxlist.com/cozaar-drug/patient-how-to-take.html  19.4 12 11.34 
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bf520a2a50e-a6ae-0fdf-9be4e69729c0  22.5 12 14.98 
http://www.auburnhospital.org/patient-education/hw-view.php?DOCHWID=d03821a1  53.7 9.1 11.6 
http://www.wikidoc.org/index.php/Losartan_%28patient_information%29  52.4 9.1 10.43 
http://rxoutreach.org/medicationmonograph/LosartanPotassium/Cozaar%C2%AE/Blood_pressure-
Heart/  
53.2 9.2 11.14 
https://www.mskcc.org/cancer-care/patient-education/valsartan  78.6 4.8 7.43 
http://www.rxlist.com/script/main/mobileartrx.asp?drug=diovan&monotype=multum&monopage=12  56.9 8.2 11.6 
http://www.upmc.com/patients-visitors/education/cardiologydrugs/Pages/valsartan.aspx  66.8 6.3 8.24 
http://www.mayoclinic.org/drugs-supplements/valsartan-oralroute/description/DRG-20067355  59.6 8.6 10.79 
https://www.drugs.com/cdi/diovan.html  54.3 8.7 11.54 
http://www.grandtraversesurgery.com/health-library/hw-view.php?DOCHWID=d04113a1  52.9 9.1 11.6 
https://advancedurologicassociates.com/patient-education/hw-view.php?DOCHWID=d04113a1  53 9 11.47 
http://www.rxlist.com/diovan-drug.htm  28 12 11.4 
http://reference.medscape.com/drug/diovan-valsartan-342325  42.3 8.7 13.02 
https://patient.info/medicine/valsartan-an-angiotensin-receptor-blockerdiovan  59.6 8.8 10.43 
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62ee362f- 
3032-4f56-a900-4d2485b8759c 
26.3 12 14.79 
http://umm.edu/health/medical/drug-notes/notes/valsartan-by-mouth  51.5 9.1 10.28 
http://www.empr.com/diovan/drug/110/  16.7 12 13.74 
http://oregon-ent.com/patient-education/hw-view.php?DOCHWID=d04113a1  53.5 9 11.28 
https://medlineplus.gov/druginfo/meds/a697015.html  50.8 9.8 10.93 
https://www.blinkhealth.com/valsartan/info        
http://www.veteranshealthlibrary.org/MedicationsVA/121,918  68.2 6.6 9.73 
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Table 2: comparison of different DISCERN 
scores for different studies 
Topics Discern 
score 
Bunions [34] 2.9 
Hip resurfacing [35] 2.3 
General Anesthesia [36] 3.2 
Inflammatory bowel 
disease [15] 
3.2 
 
 
  
  
  
 
 
 
 
 
Figure 1: mean quality rating of websites using the DISCERN instrument 
 
Table 3: category breakdown of readability scores of ARB 
websites (n=24) 
Readability 
tools 
Category Number of 
websites 
FRES Easy (80-100) 1 
  Average (60-79) 3 
  Difficult (0-59) 20 
FKRGL Up to grade 6 1 
  Grade 6-10 17 
  Beyond grade 10 6 
SMOG   Up to grade 6 - 
  Grade 6-10 3 
  Beyond grade 10 21 
